Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2010
12/22/2010EP2264014A1 Substituted pyridazines as anti-inflammatory agents and protein kinase inhibitors
12/22/2010EP2263751A1 Isoxazole compound for the treatment of cancer
12/22/2010EP2263709A1 Medical device having hydration inhibitor
12/22/2010EP2263697A2 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
12/22/2010EP2263693A1 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
12/22/2010EP2263682A1 Use of polypeptides of the cupredoxin family in cancer therapy
12/22/2010EP2263681A1 Separation and formulation of bioactive fraction and subfraction from camel urine work as anticancer agent
12/22/2010EP2263677A1 New therapeutical uses of inecalcitol
12/22/2010EP2263669A1 Pharmaceutically active isoindoline derivatives
12/22/2010EP2263668A1 Use of tea polyphenols in preparing medicaments for prevention or treatment of tumors
12/22/2010EP2263652A1 Aerosols comprising nanoparticle drugs
12/22/2010EP2263651A2 Low viscosity liquid dosage forms
12/22/2010EP2263650A2 Nanoparticulate megestrol formulations
12/22/2010EP2263465A1 Polyvalent conjugate vaccine for cancer
12/22/2010EP2262836A1 Antibody against the csf-1 r
12/22/2010EP2262833A1 Synthetic scfv analogue to the 6313/g2 (anti angiotensin ii type 1 receptor) monoclonal antibody variable regions
12/22/2010EP2262825A2 Process to produce fibrillar proteins and method of treating using fibrillar proteins
12/22/2010EP2262809A1 Benzophenone-piperazine linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof
12/22/2010EP2262807A1 Novel tyrosine kinase inhibitors
12/22/2010EP2262806A1 Pyrrolotriazine kinase inhibitors
12/22/2010EP2262805A1 Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof
12/22/2010EP2262804A1 Polysubstituted derivatives of 6-heteroaryl-imidazo[l,2- a] pyridines, and preparation and therapeutic use thereof
12/22/2010EP2262803A1 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof
12/22/2010EP2262802A1 Pim kinase inhibitors and methods of their use
12/22/2010EP2262796A1 Aurora kinase inhibitors
12/22/2010EP2262793A2 Nilotinib hci crystalline forms
12/22/2010EP2262787A1 Use of xanthone derivatives as a medicament for cancer
12/22/2010EP2262775A1 (e)-n-(2-amino-phenyl)-3-{1-[4-(1-methyl-1h-pyrazol-4-yl)-benzenesulfonyl]-1h-pyrrol-3-yl}-acrylamide salts
12/22/2010EP2262772A1 Quinoline derivatives as axl kinase inhibitors
12/22/2010EP2262769A1 Polysubstituted 2-aryl-6-phenyl-imidazo[1,2-a]pyridine derivatives, and preparation and therapeutic use thereof
12/22/2010EP2262541A1 C2orf18 as target gene for cancer therapy and diagnosis
12/22/2010EP2262540A2 Latency associated protein construct with aggrecanase sensitive cleavage site
12/22/2010EP2262537A1 Polymer paclitaxel conjugates and methods for treating cancer
12/22/2010EP2262531A1 Engineered fusion molecules immunotherapy in cancer and inflammatory diseases
12/22/2010EP2262524A2 Compositions and methods for treating pathologic angiogenesis and vascular permeability
12/22/2010EP2262523A1 Improved anticancer treatments
12/22/2010EP2262504A1 Combination therapy 238
12/22/2010EP2262500A1 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
12/22/2010EP2262499A1 Method of treating cancer using a neuropeptide y 5r (np y5r) antagonist
12/22/2010EP2262498A2 Pyrimidines and pyridines useful as inhibitors of protein kinases
12/22/2010EP2262494A2 Inhibition of post-radiation tumor growth by an inhibitor of vasculogenesis
12/22/2010EP2262493A1 Methods of treatment employing prolonged continuous infusion of belinostat
12/22/2010EP2262371A1 Lpa receptor agonists and antagonists
12/22/2010EP2262366A1 Compounds and methods for treating estrogen receptor-related diseases
12/22/2010EP2001894B1 Novel bis-2-difluoro-pyrrolo[2,1-c][1,4]benzodiazepine dimmers
12/22/2010EP1993595B1 Tumour vaccine comprising allogeneic or xenogeneic tumour cells
12/22/2010EP1915345B1 Fluoro substituted 2-oxo azepan derivatives
12/22/2010EP1891066B1 Compounds and compositions as protein kinase inhibitors
12/22/2010EP1848456B1 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity
12/22/2010EP1845957B1 Method for producing a drug extract that contains hydroxystilbenes
12/22/2010EP1824886B1 Fully human monoclonal antibodies to il-13
12/22/2010EP1804800B1 Use of 4-(4-methylpiperazin-1-ylmethyl)-n-4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl¨-benzamide to inhibit the tyrosine kinase receptor c-fms
12/22/2010EP1784396B1 Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
12/22/2010EP1730196B1 Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth
12/22/2010EP1676862B1 Recombinant antibody against human insulin-like growth factor
12/22/2010EP1536843B1 Radiolabeled compounds and liposomes and their methods of making and using the same
12/22/2010EP1412317B1 Retinoid derivatives with antiangiogenic, antitumor and proapoptotic activities
12/22/2010EP1364660B1 Drug-releasing system of biodegradable polymer type
12/22/2010EP1290182B1 Sphingosine kinase and uses thereof
12/22/2010CN1812973B Indazole compounds useful as protein kinase inhibitors
12/22/2010CN1662242B Pharmaceutical compositions for the treatment of diseases related to neurotrophines
12/22/2010CN1547477B Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
12/22/2010CN1481390B Immunomodulatory peptides derived from heat shock proteins and uses thereof
12/22/2010CN101925612A Antibodies against cancer-associated epitope of variant nfkbib and uses thereof
12/22/2010CN101925601A Enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid, its use in medical therapy, and pharmaceutical composition comprising it - 026
12/22/2010CN101925595A Phthalazinone derivatives
12/22/2010CN101925584A Pyrimidine derivatives for treatment of asthma, COPD, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, HIV, HPV, bacterial infections and dermatosis
12/22/2010CN101925583A Pyridazine derivatives useful as fungicides and for treatment of cancer
12/22/2010CN101925577A Salt forms of 6-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene derivative, process for their manufacture and pharmaceutical compositions containing same
12/22/2010CN101925573A Novel N-(2-amino-phenyl)-amide derivatives
12/22/2010CN101925367A Targeted radiotherapy
12/22/2010CN101925356A Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising liposome preparation
12/22/2010CN101925351A Cytostatic composition
12/22/2010CN101923095A Identification and application of breast cancer suppressor protein
12/22/2010CN101921820A Preparation method of recombinant tumor specificity antiapoptotic factors with activity and application of products thereof
12/22/2010CN101921816A Preparation method and use of xanthone derivative
12/22/2010CN101921805A Plasmid-mediated telomerase RNA gene interference constructing body and constructing method thereof
12/22/2010CN101921772A Human antibodies that bind human IL-12 and methods for producing
12/22/2010CN101921769A Recombinant adenovirus, preparation method and application thereof
12/22/2010CN101921733A Preparation method and application of Qbeta-2aa phage virus-like particle protein
12/22/2010CN101921721A New marine Verrucosispora sp.FIM06031 and application thereof
12/22/2010CN101921711A Alternarlactam and preparation method and application thereof
12/22/2010CN101921587A Fluorescent probe having tumor cell proliferation inhibition activity and preparation method thereof
12/22/2010CN101921346A Radial flow chromatography
12/22/2010CN101921330A Recombinant human interferon alpha 1b mutant and preparation method thereof
12/22/2010CN101921329A Alpha interferon mutant and polyethylene glycol derivative thereof
12/22/2010CN101921313A Polypeptide for curing or preventing cancer or derivative product and application thereof
12/22/2010CN101921303A Benzisoselenazolone difluorocytidine compound as well as preparation method and application thereof
12/22/2010CN101921294A Substituted benzodihydropyran derivatives and anti-tumor application thereof
12/22/2010CN101921292A Novel siRNA chemical modification monomer, preparation method thereof and use thereof
12/22/2010CN101921271A Pyridine [2,3-d] pyrimidone compounds and application thereof to pharmacy
12/22/2010CN101921270A Mangiferin berberine salt, preparation method thereof and use thereof
12/22/2010CN101921268A 5-thiazole amide compound and biology application thereof
12/22/2010CN101921267A Beta -lactamyl vasopressin Vla antagonists
12/22/2010CN101921266A 3,4,6-triaryl-[1,3]-oxazine compound as well as preparation method and application thereof
12/22/2010CN101921255A Azaphilone derivatives as well as preparation method and application thereof
12/22/2010CN101921238A Preparation of substituted nitrogen-containing benzoheterocycle derivatives and pharmacological application thereof
12/22/2010CN101921236A 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
12/22/2010CN101921227A 5-chloro-4-hydroxyl-2(1H)-pyridone crystal form, preparation method and application thereof
12/22/2010CN101921225A Pirfenidone compound, preparation method and application thereof
1 ... 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 ... 2211